Viewing Study NCT02362620


Ignite Creation Date: 2025-12-25 @ 4:29 AM
Ignite Modification Date: 2026-02-25 @ 6:43 PM
Study NCT ID: NCT02362620
Status: UNKNOWN
Last Update Posted: 2020-01-27
First Post: 2015-02-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: PROSTAC: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Docetaxel or Cabazitaxel.
Sponsor: Centro Nacional de Investigaciones Oncologicas CARLOS III
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module